Search - tctmd.com

Displaying 1 - 20 of 1065

Sort: Relevancy | Date

News Conference News ACC 2026

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

Todd Neale

April 01, 2026

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Todd Neale

March 04, 2026

Presentation THT 2026

Over-Reliance on echocardiogram: A story of missed TAVR failure aortic regurgitation.

Presenter: Norman Zheng

March 04, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

Presentation TCT 2025

CASE 4: Aortic Regurgitation and Mitral Regurgitation – Optimal Timing, Role of Surgery, and Staged Approaches

Presenter: Guido Ascione

October 28, 2025

Presentation TCT 2025

CASE 1 - Aortic Stenosis and Mitral Regurgitation – Many Shades of Gray

Presenter: Mahesh V. Madhavan

October 28, 2025

Presentation TCT 2025

TCT 1171: Noncoronary sinus pivot implantation (NCPI) strategy for transcatheter aortic valve replacement with self-expanding valve in pure native aortic regurgitation: a multicenter, registry study from the CCA Database-NTCVR

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 1426: Two Pumps, One Heartbeat: When TAVR Goes South, Impellas Go In

Presenter: Mazhed Kheyrbek

October 28, 2025

Presentation TCT 2025

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

Presenter: Ho On Alston Conrad Chiu

October 28, 2025

Presentation TCT 2025

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

Presenter: Chih-Fan Yeh

October 28, 2025

Presentation TCT 2025

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

Presenter: Ankit Gauba

October 28, 2025

Presentation TCT 2025

TCT 1422: TAVR in Severe Aortic Regurgitation Secondary to Acquired Aortico-Left Ventricular Fistula

Presenter: Amr Mohsen

October 28, 2025

Presentation TCT 2025

Dedicated Technologies for Treatment of Aortic Regurgitation

Presenter: Nicholas Stephen Amoroso

October 28, 2025

Presentation TCT 2025

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

Advertisement

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Over-Reliance on echocardiogram: A story of missed TAVR failure aortic regurgitation.

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

CASE 4: Aortic Regurgitation and Mitral Regurgitation – Optimal Timing, Role of Surgery, and Staged Approaches

CASE 1 - Aortic Stenosis and Mitral Regurgitation – Many Shades of Gray

TCT 1171: Noncoronary sinus pivot implantation (NCPI) strategy for transcatheter aortic valve replacement with self-expanding valve in pure native aortic regurgitation: a multicenter, registry study from the CCA Database-NTCVR

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

TCT 1426: Two Pumps, One Heartbeat: When TAVR Goes South, Impellas Go In

TCT 1425: Transfemoral Transcatheter Aortic Valve Implantation in Severe Aortic Regurgitation (AR) Due to Aortic Valve Leaflet Perforation: Pure AR-Dedicated Device

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

TCT 1422: TAVR in Severe Aortic Regurgitation Secondary to Acquired Aortico-Left Ventricular Fistula

Dedicated Technologies for Treatment of Aortic Regurgitation

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content